Your browser doesn't support javascript.
loading
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.
Shaim, Hila; Estrov, Zeev; Harris, David; Hernandez Sanabria, Mayra; Liu, Zhiming; Ruvolo, Peter; Thompson, Phillip A; Ferrajoli, Alessandra; Daher, May; Burger, Jan; Muftuoglu, Muharrem; Imahashi, Nobuhiko; Li, Li; Liu, Enli; Alsuliman, Abdullah Saleh; Basar, Rafet; Nassif Kerbauy, Lucila; Sobieski, Catherine; Gokdemir, Elif; Kondo, Kayo; Wierda, William; Keating, Michael; Shpall, Elizabeth J; Rezvani, Katayoun.
Afiliação
  • Shaim H; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Harris D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Hernandez Sanabria M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Liu Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ruvolo P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Thompson PA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Daher M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Burger J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Muftuoglu M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Imahashi N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Li L; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Liu E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Alsuliman AS; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Basar R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Nassif Kerbauy L; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Sobieski C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Gokdemir E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Kondo K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Keating M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Front Immunol ; 8: 1773, 2017.
Article em En | MEDLINE | ID: mdl-29379494
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos